Cargando…
Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy
Molecular-targeted therapy has been developed for cancer chemoprevention and treatment. Cancer cells have different metabolic properties from normal cells. Normal cells mostly rely upon the process of mitochondrial oxidative phosphorylation to produce energy whereas cancer cells have developed an al...
Autores principales: | Wang, Zhiyu, Wang, Neng, Chen, Jianping, Shen, Jiangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403522/ https://www.ncbi.nlm.nih.gov/pubmed/22844340 http://dx.doi.org/10.1155/2012/873175 |
Ejemplares similares
-
Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine
por: Cheng, Chien-shan, et al.
Publicado: (2014) -
Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
por: Akins, Nicholas S., et al.
Publicado: (2018) -
Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway
por: Zheng, Yifeng, et al.
Publicado: (2019) -
YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery
por: Li, Baiqing, et al.
Publicado: (2018) -
Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
por: Sun, Qiang, et al.
Publicado: (2021)